PharmacoEconomics & Outcomes News 640 - 29 Oct 2011

■ Apotex has announced its successful patentchallenge, allowing the delivery of a genericalternative to Xalatan [latanoprost] in Canada. Apo-latanoprost was released into the market on 3 October2011, almost 3 years ahead of the patent expiry,following the legal breakthrough at the Court ofAppeal. Savings to the Canadian healthcare system areexpected to be in the region of $30 million, allowingthe provinces to reinvest into vital areas of healthcare.Apotex President, Jake Kay, says "it’s only through thesupport of pharmacy as well as the public and privatedrug plans, that Apotex can continue to take on patentchallenges to deliver cost saving medications tomarket sooner".Apotex Inc. Another legal breakthrough - Latanoprost Ophthalmic Solution.Media Release : 11 Oct 2011. Available from: URL: http://www.apotex.com 809129666

1

PharmacoEconomics & Outcomes News 29 Oct 2011 No. 6401173-5503/10/0640-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved